logo
logo

Optina Announces A Us$2.1M Investment From The Diagnostics Accelerator At The Alzheimer's Drug Discovery Foundation (Addf)

Optina Announces A Us$2.1M Investment From The Diagnostics Accelerator At The Alzheimer's Drug Discovery Foundation (Addf)

01/24/22, 9:15 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/CA.svgmontreal
Money raised
$2.1 million
Round Type
seed
Optina, an innovative diagnostics company, leader in retinal imaging, brain health and systemic disease detection, announces the closing of an up to US$2.1M investment from the Alzheimer's Drug Discovery Foundation (ADDF). The investment will be made through the ADDF's Diagnostics Accelerator, a collaborative research initiative supported by ADDF's Co-Founder Leonard A. Lauder, Bill Gates, Jeff Bezos, MacKenzie Scott, the Dolby family, and the Charles and Helen Schwab Foundation, among others, to advance the most promising early diagnostics for Alzheimer's disease. This funding comes on the tail of closing an oversubscribed Series-A round led by DigitalDx Ventures including Boehringer Ingelheim Venture Fund, Desjardins, Zoic Capital as well as other investors.

Company Info

Company
Optina Diagnostics
Location
montreal, quebec, canada
Additional Info
Optina Diagnostics is a Montreal-based company focused on changing mindsets when it comes to Brain Health and systemic diseases. With a first application in the early diagnosis of Alzheimer's, Optina challenges the status quo by providing an accurate, simple, and non-invasive optical test to understand the age-related sources of memory loss, empowering millions. optinadx.com.